Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
JAMA Cardiology
|
October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
Akshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
Heart (British Cardiac Society)
|
August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Paul R Kalra, John Gf Cleland, Mark C Petrie, et al.
JAMA Cardiology
|
June 23, 2021
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction
Christopher J Rush, Colin Berry, Keith G Oldroyd, et al.
JACC. Cardiooncology
|
October 9, 2025
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma
Claire Glen, Stephen J H Dobbin, Kenneth Mangion, et al.
Circulation. Heart Failure
|
June 29, 2022
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity
Peter A Henriksen, Peter Hall, Olga Oikonomidou, et al.
Journal of the American Heart Association
|
February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF
Solmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.
ESC Heart Failure
|
May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Heart (British Cardiac Society)
|
February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
Shirley Sze, Iain Squire, Paul R Kalra, et al.
Circulation
|
October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial
Novalia P Sidik, Bethany Stanley, Robert Sykes, et al.
European Journal of Heart Failure
|
October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial
Paul W Foley, Paul R Kalra, John G F Cleland, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
JAMA Cardiology
|
October 3, 2022
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
Akshay S Desai, Pardeep S Jhund, Brian L Claggett, et al.
Heart (British Cardiac Society)
|
August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
Paul R Kalra, John Gf Cleland, Mark C Petrie, et al.
JAMA Cardiology
|
June 23, 2021
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction
Christopher J Rush, Colin Berry, Keith G Oldroyd, et al.
JACC. Cardiooncology
|
October 9, 2025
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma
Claire Glen, Stephen J H Dobbin, Kenneth Mangion, et al.
Circulation. Heart Failure
|
June 29, 2022
Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity
Peter A Henriksen, Peter Hall, Olga Oikonomidou, et al.
Journal of the American Heart Association
|
February 1, 2021
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF
Solmaz Ehteshami-Afshar, Leanne Mooney, Pooja Dewan, et al.
ESC Heart Failure
|
May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Heart (British Cardiac Society)
|
February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
Shirley Sze, Iain Squire, Paul R Kalra, et al.
Circulation
|
October 5, 2023
Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial
Novalia P Sidik, Bethany Stanley, Robert Sykes, et al.
European Journal of Heart Failure
|
October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial
Paul W Foley, Paul R Kalra, John G F Cleland, et al.
Page
of 9